Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
PT-141 (Bremelanotide)
Course Target: Neuroendocrinology, Behavioral Pharmacology, and Sexual Medicine.
Core Focal Point: Melanocortin Receptor Agonism and Central Nervous System Signaling.
1. Molecular Structure & Origin
PT-141 is a synthetic cyclic heptapeptide (a 7-amino acid chain ring structure).
The Evolutionary Accident: It was originally developed as a sunless tanning peptide called Melanotan II. During clinical testing, researchers noticed that while it did darken skin pigmentation, it also unexpectedly triggered intense sexual arousal in test subjects.
The Modification: Scientists isolated the exact metabolite responsible for the arousal effect and stripped away the tanning mechanism, creating PT-141.
2. 🎯 The Central Nervous System Mechanism: How It Works
To explain PT-141 to your class, use the phrase "The Neurological Spark." Unlike traditional drugs like Viagra or Cialis (PDE5 inhibitors)—which simply open up local blood vessels—PT-141 bypasses the body entirely and works inside the brain.
[PT-141 Subcutaneous Injection]
│
▼
[Crosses the Blood-Brain Barrier (BBB)]
│
▼
[Binds to MC3R and MC4R Receptors in Hypothalamus]
│
▼
[Triggers Dopamine Release & Behavioral Arousal Cascades]
│
▼
[Direct Activation of Sexual Desire & Physiological Function]
Step 1: Crossing the Barrier
Once injected, PT-141 enters the bloodstream and easily crosses the blood-brain barrier (BBB) to gain direct access to the central nervous system.
Step 2: Melanocortin Receptor Activation.
Inside the brain, it bypasses hormonal pathways and binds directly as a non-selective agonist to Melanocortin Receptors, specifically MC3R and MC4R, located heavily in the medial preoptic area of the hypothalamus.
Step 3: Unleashing the Behavioral Cascade
Activating these receptors triggers a rapid downstream release of dopamine (the brain's reward and desire chemical). This neural pathway instantly overrides psychological blockages, directly stimulating sexual desire, motivation, and physiological arousal responses in both men and women.
3. Primary Clinical Conditions That Benefit From PT-141
1. Hypoactive Sexual Desire Disorder (HSDD) in Women.
The Disease: A chronic psychological and physical condition where premenopausal women experience a complete, distressing lack of sexual desire or fantasies.
How PT-141 Helps: It is a landmark therapeutic. In 2019, the FDA officially approved PT-141 under the brand name Vyleesi specifically to treat generalized HSDD in women, successfully restoring normal neurological desire pathways.
2. Psychogenic Erectile Dysfunction (ED) in Men.
The Disease: Erectile dysfunction that is caused by performance anxiety, severe stress, or mental blockages, rather than a physical blood-flow problem.
How PT-141 Helps: Because it targets the brain's dopamine pathways rather than the vascular system, PT-141 successfully bypasses physical ED limitations, providing a potent alternative for men who do not respond to or cannot safely take traditional drugs like Viagra.
Traditional ED drugs are mechanical—they just fix the body's plumbing. PT-141 is neurological—it fixes the brain's software. It forces the central nervous system to fire dopamine signals, treating the root psychological and behavioral components of intimacy disorders."
Product Details
• Compound: PT-141
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.
PT-141 (Bremelanotide)
Course Target: Neuroendocrinology, Behavioral Pharmacology, and Sexual Medicine.
Core Focal Point: Melanocortin Receptor Agonism and Central Nervous System Signaling.
1. Molecular Structure & Origin
PT-141 is a synthetic cyclic heptapeptide (a 7-amino acid chain ring structure).
The Evolutionary Accident: It was originally developed as a sunless tanning peptide called Melanotan II. During clinical testing, researchers noticed that while it did darken skin pigmentation, it also unexpectedly triggered intense sexual arousal in test subjects.
The Modification: Scientists isolated the exact metabolite responsible for the arousal effect and stripped away the tanning mechanism, creating PT-141.
2. 🎯 The Central Nervous System Mechanism: How It Works
To explain PT-141 to your class, use the phrase "The Neurological Spark." Unlike traditional drugs like Viagra or Cialis (PDE5 inhibitors)—which simply open up local blood vessels—PT-141 bypasses the body entirely and works inside the brain.
[PT-141 Subcutaneous Injection]
│
▼
[Crosses the Blood-Brain Barrier (BBB)]
│
▼
[Binds to MC3R and MC4R Receptors in Hypothalamus]
│
▼
[Triggers Dopamine Release & Behavioral Arousal Cascades]
│
▼
[Direct Activation of Sexual Desire & Physiological Function]
Step 1: Crossing the Barrier
Once injected, PT-141 enters the bloodstream and easily crosses the blood-brain barrier (BBB) to gain direct access to the central nervous system.
Step 2: Melanocortin Receptor Activation.
Inside the brain, it bypasses hormonal pathways and binds directly as a non-selective agonist to Melanocortin Receptors, specifically MC3R and MC4R, located heavily in the medial preoptic area of the hypothalamus.
Step 3: Unleashing the Behavioral Cascade
Activating these receptors triggers a rapid downstream release of dopamine (the brain's reward and desire chemical). This neural pathway instantly overrides psychological blockages, directly stimulating sexual desire, motivation, and physiological arousal responses in both men and women.
3. Primary Clinical Conditions That Benefit From PT-141
1. Hypoactive Sexual Desire Disorder (HSDD) in Women.
The Disease: A chronic psychological and physical condition where premenopausal women experience a complete, distressing lack of sexual desire or fantasies.
How PT-141 Helps: It is a landmark therapeutic. In 2019, the FDA officially approved PT-141 under the brand name Vyleesi specifically to treat generalized HSDD in women, successfully restoring normal neurological desire pathways.
2. Psychogenic Erectile Dysfunction (ED) in Men.
The Disease: Erectile dysfunction that is caused by performance anxiety, severe stress, or mental blockages, rather than a physical blood-flow problem.
How PT-141 Helps: Because it targets the brain's dopamine pathways rather than the vascular system, PT-141 successfully bypasses physical ED limitations, providing a potent alternative for men who do not respond to or cannot safely take traditional drugs like Viagra.
Traditional ED drugs are mechanical—they just fix the body's plumbing. PT-141 is neurological—it fixes the brain's software. It forces the central nervous system to fire dopamine signals, treating the root psychological and behavioral components of intimacy disorders."
Product Details
• Compound: PT-141
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.